DiA Imaging Analysis, a Beer Sheva, Israel-based provider of advanced AI-based solutions for ultrasound analysis, raised $14m in additional funding.
Backers included new investors XTX Ventures, Downing Ventures, Philips, Alchimia Ventures, and ICON Community Fund and existing investors CE Ventures, Connecticut Innovations, Defta Partners, Mindset Ventures, and Dr. Shmuel Cabilly.
The company intends to use the funds to:
- expand its portfolio of solutions,
- pursue new and expanded partnerships with ultrasound vendors, PACS/Healthcare IT companies, resellers, and distributors, and
- grow its global presence in Asia, Europe, and the U.S.
Led by Hila Goldman Aslan, CEO and Co-Founder, DiA Imaging Analysis provides a portfolio of FDA-cleared and CE-marked AI-based ultrasound solutions that enable clinicians to identify clinical abnormalities with speed and accuracy. Its AI-based technology imitates the way the human eye detects borders and identifies motion, allowing clinicians of all levels of experience to capture the right ultrasound images and automatically identify clinical abnormalities that are otherwise difficult to find visually. The company’s vendor-neutral and cross-platform solutions, LVivo Toolbox, is currently serving thousands of end-users in more than 20 countries, deployed on ultrasound devices and healthcare IT systems.
DiA has secured channel and commercial partnerships with several major healthcare technology providers and distributors including IBM Watson, Philips, GE Healthcare, and Konica Minolta, among others.
DiA also announced that Dr. Diku Mandavia has joined the Board of Directors as an industry board member. Having served as SonoSite’s (Fujifilm company) Chief Medical Officer for nearly 15 years, Dr. Mandavia is recognized as an expert and thought leader in point-of-care ultrasound technologies.